Buy GLOW: Peptide Blend for Tissue Regeneration and Skin

GLOW is a three-component peptide blend specifically developed for the study of tissue regeneration and skin biology. The combination of BPC-157, TB-500 and GHK-Cu brings together three of the most extensively studied peptides in regeneration research in a single vial, with a focus on collagen synthesis, tissue repair and dermal renewal.

GLOWregeneration

3-in-1 skin peptide blend: GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg. Targets collagen synthesis, tissue regeneration, and skin repair for comprehensive dermatological research.

For those looking to source GLOW for research purposes, here is everything essential: composition, scientific background and practical notes on quality, storage and sourcing.

What Is GLOW?

GLOW is a proprietary peptide blend with a total weight of 70 mg, consisting of three bioactive components:

BPC-157 (Body Protection Compound-157): Perhaps the most extensively documented healing peptide in preclinical research. Derived from a protective protein in gastric juice, its effects on tendons, muscles, bones and the gastrointestinal mucosa have been studied in hundreds of publications (Sikiric et al., 1999-2026).
TB-500 (Thymosin Beta-4 Fragment): A 43-amino acid peptide with a central role in actin regulation. TB-500 promotes cell migration and angiogenesis and has been particularly studied in wound healing and cardiac regeneration (Goldstein et al., 2005).
GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper): A naturally occurring copper tripeptide detected in human plasma, saliva and urine. Its blood concentration declines with age from approximately 200 ng/ml in young adults to about 80 ng/ml in the elderly. GHK-Cu is one of the most potent known stimulators of collagen synthesis.

Why This Particular Combination?

The GLOW blend differs from the KLOW blend by the absence of KPV, shifting its focus away from inflammation control and more towards structural regeneration and skin biology.

The Research Foundation

BPC-157 and Tissue Repair: A systematic review published in 2025 by Vasireddi et al. in orthopaedic sports medicine confirms the potential of BPC-157 for healing musculoskeletal injuries - fractures, tendon ruptures, ligament injuries and muscle injuries. The mechanisms of action include VEGF upregulation, activation of the FAK-paxillin pathway and modulation of the NO system.

TB-500 and Cell Migration: Thymosin Beta-4 is the most abundant actin-sequestering peptide in eukaryotic cells. Research shows that TB-500 promotes the formation of new blood vessels, modulates inflammation and supports the migration of stem cells to sites of tissue damage.

GHK-Cu and Skin Biology: The research evidence for GHK-Cu is impressive. Pickart et al. (2018, Cosmetics) document that GHK-Cu influences the expression of over 4,000 genes. In clinical studies, topically applied GHK-Cu improved collagen production in 70% of treated subjects - superior to vitamin C cream (50%) and retinoic acid (40%). Kruger et al. confirmed a significant increase in skin thickness, improved hydration and enhanced skin elasticity.

Mechanisms of Action

The three peptides complement each other at multiple levels:

Angiogenesis: BPC-157 (via VEGF/EGF) and TB-500 (via actin reorganisation) promote the formation of new blood vessels through different mechanisms.
Collagen Synthesis: GHK-Cu is the primary driver, but BPC-157 also stimulates the production of type I collagen in fibroblasts.
Cell Migration: TB-500 regulates actin polymerisation, facilitating the movement of repair cells to damaged tissue.
Gene Expression: GHK-Cu modulates the expression of thousands of genes, including those associated with tissue repair, inflammation reduction and stem cell activation.

Quality Criteria When Buying

For a multi-peptide blend, analytics are decisive. Researchers should look for the following criteria:

Independent Verification: Every GLOW batch at PeptidesDirect is tested by Janoshik Analytical, with HPLC purity analyses and mass spectrometry for each individual component.
Purity ≥98%: Research-grade quality means at least 98% purity per peptide. Lower purity grades can compromise research results.
Correct Component Ratios: The precise dosage of each component within the 70 mg blend must be documented and reproducible.

Dosages in Research Literature

No specific dosage studies exist for the GLOW blend as a whole product. However, the individual components are well characterised:

BPC-157: 200-500 µg subcutaneously, based on animal models at ~10 µg/kg (Sikiric et al.).
TB-500: 2-5 mg initial, followed by 1-2 mg maintenance dose in research protocols.
GHK-Cu: In topical studies 1-10 µg/ml. For systemic application in research, protocols vary depending on the research question.

The overall dosage of the GLOW blend depends on the specific research design.

Storage and Handling

GLOW is supplied as a lyophilised powder:

Unopened: Store at -20 °C. Stable in this form for months.
After reconstitution: Store in the refrigerator at 2-8 °C. Use within 2-4 weeks.
Reconstitution: Allow bacteriostatic water to run slowly down the vial wall. Gently swirl, do not shake. The solution should be clear.
Light protection: GHK-Cu contains copper ions that are light-sensitive. Use dark vials or store protected from light.

Why Buy GLOW from PeptidesDirect?

Janoshik-verified: Independent analytics for every batch, with accessible certificates of analysis.
EU shipping: Shipped from within the EU - no customs, no import fees, no border risk.
Delivery time: 2-3 business days with tracking.
Research-grade: At least 98% purity for all three components.

GLOW 70 mg is available at PeptidesDirect for €135.99.

Frequently Asked Questions

What is GLOW used for? Exclusively for in-vitro and preclinical research. GLOW is not an approved medicine and is not intended for human consumption.

What is the difference between GLOW and KLOW? KLOW additionally contains KPV, an anti-inflammatory tripeptide. GLOW focuses on the three core regeneration peptides BPC-157, TB-500 and GHK-Cu, with a stronger emphasis on structural tissue repair and collagen synthesis rather than inflammation control.

Can GLOW be combined with other peptides? Multi-peptide approaches are frequently studied in research. Combination with other peptides depends on the specific research protocol. Researchers should consider potential interactions in their experimental design.

How do I recognise research-grade quality? A meaningful Certificate of Analysis (COA) with HPLC purity analysis, mass spectrometry and peptide content data for each component is the minimum. Independent testing by a recognised laboratory such as Janoshik Analytical provides additional assurance.

Are there clinical studies on GLOW? Not for the specific blend. For GHK-Cu, clinical data exists on topical application (collagen production, skin thickness, skin elasticity). BPC-157 and TB-500 are so far documented exclusively in preclinical studies.

GLOWregeneration

3-in-1 skin peptide blend: GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg. Targets collagen synthesis, tissue regeneration, and skin repair for comprehensive dermatological research.